{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260604863826/en/Mirum-Pharmaceuticals-and-Incyte-Announce-Pivotal-Late-Breaking-Results-for-Zilurgisertib-in-Fibrodysplasia-Ossificans-Progressiva-Accepted-for-Presentation-at-ENDO-2026", "message": "News view counter 780474 successfully enlarged"}